Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shi-Ying Cai

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 21, 2006
Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodentsJames L Boyer, Michael Trauner, Albert Mennone, et al.
Acta Pharmacologica Sinica|April 3, 2015
The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathwayDong-ke Yu, Cai-xia Zhang, Shuang-shuang Zhao, et al.
Molecules (Basel, Switzerland)|June 12, 2013
Arylsulfonylamino-benzanilides as inhibitors of the apical sodium-dependent bile salt transporter (SLC10A2)Hong-Tao Liu, Hong-Wei He, Xiao-Guang Bai, et al.
JCI Insight|March 15, 2017
Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory responseShi-Ying Cai, Xinshou Ouyang, Yonglin Chen, et al.
Hepatology (Baltimore, Md.)|November 23, 2011
Elevated hepatic multidrug resistance-associated protein 3/ATP-binding cassette subfamily C 3 expression in human obstructive cholestasis is mediated through tumor necrosis factor alpha and c-Jun NH2-terminal kinase/stress-activated protein kinase-signaling pathwayJin Chai, Yu He, Shi-Ying Cai, et al.
JCI Insight|May 18, 2018
Elevated hepatic expression of H19 long noncoding RNA contributes to diabetic hyperglycemiaNa Zhang, Tingting Geng, Zhangsheng Wang, et al.
Journal of Clinical Gastroenterology|July 19, 2016
Combination Therapy of All-Trans Retinoic Acid With Ursodeoxycholic Acid in Patients With Primary Sclerosing Cholangitis: A Human Pilot StudyDavid N Assis, Osama Abdelghany, Shi-Ying Cai, et al.
Journal of Hepatology|July 28, 2015
Canalicular membrane MRP2/ABCC2 internalization is determined by Ezrin Thr567 phosphorylation in human obstructive cholestasisJin Chai, Shi-Ying Cai, Xiaocong Liu, et al.
Cell Death Discovery|January 23, 2023
Hepatic TNFRSF12A promotes bile acid-induced hepatocyte pyroptosis through NFκB/Caspase-1/GSDMD signaling in cholestasisMin Liao, Junwei Liao, Jiaquan Qu, et al.
JHEP Reports : Innovation in Hepatology|September 22, 2025
Conjugated bile acid-driven CD14<sup>+</sup>CD16<sup>+</sup> monocyte infiltration promotes cholestatic liver injury by enhancing hepatocyte necroptosisZhixian Zhu, Ziqian Xu, Xinyu Cao, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 21, 2006
Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodentsJames L Boyer, Michael Trauner, Albert Mennone, et al.
Acta Pharmacologica Sinica|April 3, 2015
The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathwayDong-ke Yu, Cai-xia Zhang, Shuang-shuang Zhao, et al.
Molecules (Basel, Switzerland)|June 12, 2013
Arylsulfonylamino-benzanilides as inhibitors of the apical sodium-dependent bile salt transporter (SLC10A2)Hong-Tao Liu, Hong-Wei He, Xiao-Guang Bai, et al.
JCI Insight|March 15, 2017
Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory responseShi-Ying Cai, Xinshou Ouyang, Yonglin Chen, et al.
Hepatology (Baltimore, Md.)|November 23, 2011
Elevated hepatic multidrug resistance-associated protein 3/ATP-binding cassette subfamily C 3 expression in human obstructive cholestasis is mediated through tumor necrosis factor alpha and c-Jun NH2-terminal kinase/stress-activated protein kinase-signaling pathwayJin Chai, Yu He, Shi-Ying Cai, et al.
JCI Insight|May 18, 2018
Elevated hepatic expression of H19 long noncoding RNA contributes to diabetic hyperglycemiaNa Zhang, Tingting Geng, Zhangsheng Wang, et al.
Journal of Clinical Gastroenterology|July 19, 2016
Combination Therapy of All-Trans Retinoic Acid With Ursodeoxycholic Acid in Patients With Primary Sclerosing Cholangitis: A Human Pilot StudyDavid N Assis, Osama Abdelghany, Shi-Ying Cai, et al.
Journal of Hepatology|July 28, 2015
Canalicular membrane MRP2/ABCC2 internalization is determined by Ezrin Thr567 phosphorylation in human obstructive cholestasisJin Chai, Shi-Ying Cai, Xiaocong Liu, et al.
Cell Death Discovery|January 23, 2023
Hepatic TNFRSF12A promotes bile acid-induced hepatocyte pyroptosis through NFκB/Caspase-1/GSDMD signaling in cholestasisMin Liao, Junwei Liao, Jiaquan Qu, et al.
JHEP Reports : Innovation in Hepatology|September 22, 2025
Conjugated bile acid-driven CD14<sup>+</sup>CD16<sup>+</sup> monocyte infiltration promotes cholestatic liver injury by enhancing hepatocyte necroptosisZhixian Zhu, Ziqian Xu, Xinyu Cao, et al.
Pageof 6